FDA Warning Letter — Guangzhou Haishi Biological Technology Co., Ltd.
The FDA took a Warning Letter action against Guangzhou Haishi Biological Technology Co., Ltd. on June 22, 2016 (Guangzhou, China). The action was issued by CDER and concerns drugs products. This facility has 1 recent FDA inspection on record.
Action Details
- Facility
- Guangzhou Haishi Biological Technology Co., Ltd.
- Date
- June 22, 2016
- Fiscal Year
- 2016
- Product Type
- Drugs
- Center
- CDER
- Location
- Guangzhou (China)